Cited by 723Genetic Associations and EpidemiologyProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes

Gudmundsson, Julius, Sulem, Patrick, Steinthorsdottir, Valgerdur, Bergthorsson, Jon T, Thorleifsson, Gudmar, Manolescu, Andrei, Rafnar, Thorunn, Gudbjartsson, Daniel +67 more·2007·Nature Genetics

Abstract

We performed a genome-wide association scan to search for sequence variants conferring risk of prostate cancer using 1,501 Icelandic men with prostate cancer and 11,290 controls. Follow-up studies involving three additional case-control groups replicated an association of two variants on chromosome 17 with the disease. These two variants, 33 Mb apart, fall within a region previously implicated by family-based linkage studies on prostate cancer. The risks conferred by these variants are moderate individually (allele odds ratio of about 1.20), but because they are common, their joint population attributable risk is substantial. One of the variants is in TCF2 (HNF1beta), a gene known to be mutated in individuals with maturity-onset diabetes of the young type 5. Results from eight case-control groups, including one West African and one Chinese, demonstrate that this variant confers protection against type 2 diabetes.

Integrity signals

Registry

Crossref · 10.1038/ng2062

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These findings inform prioritization of therapeutic targets, providing clues to potential on-target side effects and opportunities for drug repurposing.

    “These findings inform the prioritization of therapeutic targets, providing clues to potential on-target side effects and opportunities for drug repurposing87–89.”

    From A brief history of human disease genetics (2020) · cites this paper as [87]

  • Other pleiotropic relationships connect diseases and traits in surprising ways, highlighting shared polygenic effects and cell-type specificity and delivering insights into shared biology and overlapping mechanisms.

    “Others connect diseases and traits in surprising ways, highlighting shared polygenic, pleiotropic effects and cell-type specificity, and delivering insights into shared biology and overlapping mechanisms86,87.”

    From A brief history of human disease genetics (2020) · cites this paper as [87]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gudmundsson, J., Sulem, P., Steinthorsdottir, V., Bergthorsson, J. T., Thorleifsson, G., Manolescu, A., Rafnar, T., Gudbjartsson, D., Agnarsson, B. A., Baker, A., Sigurdsson, A., Benediktsdottir, K. R., Jakobsdottir, M., Blondal, T., Stacey, S. N., Helgason, A., Gunnarsdottir, S., Olafsdottir, A., Kristinsson, K. T., Birgisdottir, B., Ghosh, S., Thorlacius, S., Magnusdottir, D., Stefansdottir, G., Kristjansson, K., Bagger, Y., Wilensky, R. L., Reilly, M. P., Morris, A. D., Kimber, C. H., Adeyemo, A., Chen, Y., Zhou, J., So, W.-Y., Tong, P. C. Y., Ng, M. C. Y., Hansen, T., Andersen, G., Borch-Johnsen, K., Jorgensen, T., Tres, A., Fuertes, F., Ruiz-Echarri, M., Asin, L., Saez, B., van Boven, E., Klaver, S., Swinkels, D. W., Aben, K. K., Graif, T., Cashy, J., Suarez, B. K., van Vierssen Trip, O., Frigge, M. L., Ober, C., Hofker, M. H., Wijmenga, C., Christiansen, C., Rader, D. J., Palmer, C. N. A., Rotimi, C., Chan, J. C. N., Pedersen, O., Sigurdsson, G., Benediktsson, R., Jonsson, E., Einarsson, G. V., Mayordomo, J. I., Catalona, W. J., Kiemeney, L. A., Barkardottir, R. B., Gulcher, J. R., Thorsteinsdottir, U., Kong, A., & Stefansson, K.
Affiliations
  • deCODE Genetics (Iceland) (IS)
  • National University Hospital of Iceland (IS)
  • Center for Clinical & Basic Research (DK)
  • University of Pennsylvania (US)
  • Ninewells Hospital (GB)
  • Howard University (US)
  • Chinese University of Hong Kong (HK)
  • Steno Diabetes Center Copenhagen (DK)
  • Universidad de Zaragoza (ES)
  • Radboud University Nijmegen (NL)
  • Northwestern University (US)
  • Washington University in St. Louis (US)
  • University of Chicago (US)
  • University Medical Center Groningen (NL)
  • Aarhus University (DK)
Venue
Nature Genetics
Published
2007-07-01
Volume
39
Issue
8
Pages
977-983
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W2171682260
Cited by
723
References
23
Citations by year
2026: 3 · 2025: 4 · 2024: 7 · 2023: 16 · 2022: 8 · 2021: 11 · 2020: 19 · 2019: 8 · 2018: 16 · 2017: 21 · 2016: 23 · 2015: 35 · 2014: 40 · 2013: 48 · 2012: 71
FWCI
57.65
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (submittedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Hirsla (Landspítali University Hospital) (submittedVersion)
Funders
  • Wellcome Trust
  • Radboud Universiteit
  • National Institutes of Health (5r01dk072128-04)
  • Fogarty International Center (T37TW000041, 3T37TW00041-03S2)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK072128)
  • National Center for Research Resources (RR03048)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Diagnosis and Treatment
Keywords
prostate cancer, chromosome 17, HNF1B, type 2 diabetes, genetic susceptibility, single nucleotide polymorphisms, population attributable risk
MeSH terms
Chromosomes, Human, Pair 17, Diabetes Mellitus, Type 2, Haplotypes, Humans, Male, Prostatic Neoplasms, Case-Control Studies, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Hepatocyte Nuclear Factor 1-beta

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review